AGIO – agios pharmaceuticals, inc. (US:NASDAQ)

News

Agios Pharmaceuticals (AGIO) Is Up 5.4% After Mixed 2025 Results And AQVESME Launch Progress [Yahoo! Finance]
Agios Pharmaceuticals Inc (AGIO) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]
Agios Pharmaceuticals (NASDAQ:AGIO) had its price target raised by analysts at HC Wainwright from $62.00 to $65.00. They now have a "buy" rating on the stock.
Agios Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Agios Pharmaceuticals: Q4 Earnings Snapshot [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com